Childhood ADHD medication shows protective effect against future psychosis

	Schizophrenia
	The latest schizophrenia news from News Medical

	Childhood ADHD medication shows protective effect against future psychosis A major new study, led by scientists at University College Dublin and the University of Edinburgh and funded by the St John of God Research Foundation, has found that commonly prescribed attention deficit hyperactivity disorder (ADHD) medication in childhood may lower the long‑term risk of developing serious psychotic disorders, including schizophrenia.

	Study identifies protein biomarker and potential treatment for schizophrenia Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction.

			When omega-3 may help mental health and when they may not Investigating omega-3 fatty acids, this review highlights their impact on mental health, inflammation, and the potential for therapeutic use in disorders.

			Polygenic embryo testing raises ethical concerns beyond disease prevention For more than four decades, in vitro fertilization (IVF) has helped families have children. Scientists estimate that more than 10 million people worldwide have been born through IVF and related assisted reproductive technologies, according to the International Committee for Monitoring Assisted Reproductive Technologies.

			Brain waste clearance dysfunction may predict the onset of psychosis How can we explain the onset of psychotic symptoms characteristic of schizophrenia? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological mechanisms that precede their emergence remain poorly understood.

	Key gene mutation disrupts the brain’s ability to update beliefs in schizophrenia patients One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients to struggle with making decisions and, eventually, to lose touch with reality.

	Timing of acetylcholine release determines if dopamine promotes movement or learning Scientists have long-studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order to better understand Parkinson's disease, schizophrenia, and depression-afflictions caused, in part, by a disruption or alteration of dopamine activity.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026